C02KX01 |
B |
Bosentan (monohydrate) - 62.5mg |
5493 |
221725/08 |
TRACLEER |
62.5mg |
56 |
Tablet, film coated |
Oral |
Mersaco |
Haupt Pharma Wulfing GmbH |
Germany |
79,583,961 L.L |
2.44 |
E2 |
Actelion Pharmaceuticals Ltd |
Switzerland |
05/08/20 |
889.21 |
C02KX01 |
B |
Bosentan (monohydrate) - 62.5mg |
11194 |
46622/1 |
TRACLEER |
62.5mg |
56 |
Tablet, film coated |
Oral |
Mersaco |
Haupt Pharma Wulfing GmbH |
Germany |
79,583,961 L.L |
2.44 |
E2 |
Janssen-Cilag AG |
Switzerland |
05/08/20 |
889.21 |
C02KX01 |
G |
Bosentan (monohydrate) - 62.5mg |
9468 |
179517/1 |
BOSENTAN ARROW |
62.5mg |
56 |
Tablet, film coated |
Oral |
Darapharma S.A.L. |
APL Swift Services (Malta) Limited |
Malta |
51,483,159 L.L |
10.71 |
E1 |
Arrow Génériques |
France |
05/08/20 |
575.23 |
C02KX01 |
G |
Bosentan (monohydrate) - 62.5mg |
8843 |
115316/1 |
PMS-BOSENTAN |
62.5mg |
60 |
Tablet |
Oral |
UPO S.A.L. |
Genvion Corporation |
Canada |
77,539,821 L.L |
10.71 |
E1 |
Pharmascience Inc |
Canada |
05/08/20 |
866.37 |
C02KX01 |
G |
Bosentan (monohydrate) - 62.5mg |
9468/388 |
179517/1 |
BOSENTAN ARROW |
62.5mg |
56 |
Tablet, film coated |
Oral |
Darapharma S.A.L. |
APL Swift Services (Malta) Limited |
Malta |
L.L |
10.71 |
E1 |
Arrow Génériques |
France |
05/02/20 |
|